Search for Clinical Trial Results

Sponsored By

Behcet Syndrome - 28 Studies Found

Status Study
Terminated Study Name: Tocilizumab for the Treatment of Behcet's Syndrome
Condition: Behcet Syndrome
Date: 2012-09-19
Interventions: Drug: Tocilizumab Intravenous infusions every 4 weeks for 3 doses.
Completed Study Name: Psychological Symptoms in Patients With Behcet's Disease by SCL90-R
Condition: Behcet's Syndrome
Date: 2008-06-17
Active, not recruiting Study Name: A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behcet's Disease
Condition: Behcet Syndrome
Date: 2014-12-02
Interventions:
  • Drug: Apremilast (CC-10004) Ot
Completed Study Name: Rituximab for the Treatment of Severe Ocular Manifestations of Behcet's Disease
Condition: Behcet's Syndrome
Date: 2008-04-20
Interventions:
  • Drug: Rituximab Infusion of Ri
Completed Study Name: A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet Disease
Condition: Behcet Syndrome
Date: 2009-03-18
Interventions:
  • Drug: Apremilast (CC-10004)

Active, not recruiting Study Name: A Pilot Study of the Safety and Efficacy of Abatacept Injections in the Treatment of Behcet's Syndrome
Condition: Female Patients With Behcet's Syndrome
Date: 2012-09-19
Interventions: Drug: Abatacept Weekly injections with Abatacept 125 mg over 6 months
Completed Study Name: Behçet's Disease and Eosinophil Cationic Protein
Condition: Behçet's Disease
Date: 2012-04-24
Interventions: Other: eosinophil cationic protein Serum eosinophil cationic protein levels
Completed Study Name: Special Investigation in Patients With Intestinal Behcet's Disease (All Case Investigation)
Condition: Behcet's Disease
Date: 2013-07-16
Recruiting Study Name: A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's Disease
Condition: Behcet Disease
Date: 2015-06-29
Interventions: Drug: Infliximab Participants will receive infliximab 5 milligram per kilogram (mg/kg) infusion at Week
Completed Study Name: Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions
Condition:
  • Behcet's Disease
  • Behcet Syndrome Date: 2012-02-06
    Interventions: Drug: TA-650 TA-650 will be intravenously infused at a dosage of 5 mg/kg slowly over a period of more th
Next >>>